S2N

A unique, unipotent autologous cell therapy for Alzheimer. Reversal of memory impairment & 9SD increase in synapses in AD dogs. No pluripotency or gene mods. Closed, automated, reliable CMC. Tier 1 strategic investor. 2y path to FIH. PET readout 6m later

Country

Australia
Loading